Last updated: November 2026 | By Noteskarts Team | Educational information, not medical advice
Medical disclaimer: This article is for education and general information only. It is NOT medical advice. Semaglutide is a prescription-only (Schedule H) medicine. Never start, stop, or change any medication without a qualified doctor. Prices are indicative and change frequently.
Semaglutide in India has become the biggest story in medicine this year. On 20 March 2026 the patent expired, and within a day more than eight Indian companies launched generic versions — dropping the price of the world’s most talked-about diabetes and weight-loss drug by up to 90%.
If you are a patient, a caregiver, or a pharmacy student, you need a clear picture. This guide explains what semaglutide in India actually is, every generic brand now available, real price ranges, how it compares to Mounjaro, and the safety facts that matter. Everything is written in plain English and checked against public sources in November 2026.
Semaglutide in India: quick facts
| Point | Detail |
|---|---|
| Drug class | GLP-1 receptor agonist |
| Used for | Type 2 diabetes; chronic weight management (as approved) |
| Innovator brands | Ozempic, Rybelsus, Wegovy (Novo Nordisk) |
| Patent expired | 20 March 2026 |
| Generics launched | 21 March 2026 (8+ companies) |
| Lowest entry price | ~Rs 220 per shot (generic, indicative) |
| Prescription status | Schedule H — prescription only |
| Forms available | Injection (pen/vial); oral tablet (limited) |
Prices are indicative, vary by brand and format, and change often. Always confirm with a pharmacist.
What is semaglutide, in simple terms?
Semaglutide in India is a GLP-1 receptor agonist. GLP-1 is a natural gut hormone your body releases after eating. Semaglutide copies its action, and does three useful things:
- It tells the pancreas to release insulin when blood sugar is high — which helps control type 2 diabetes.
- It slows how fast the stomach empties, so you feel full for longer.
- It acts on appetite centres in the brain, so you feel less hungry — which is why it drives weight loss.
It is sold under three innovator names, and the difference is mainly the form and the approved use:
- Ozempic — a weekly injection, approved for type 2 diabetes.
- Rybelsus — an oral tablet version of semaglutide for type 2 diabetes.
- Wegovy — a higher-dose weekly injection approved specifically for weight management.
Why semaglutide in India is suddenly everywhere
For years, semaglutide in India was expensive and under patent, so only Novo Nordisk could sell it in India. That changed overnight.
The Indian patent expired on 20 March 2026. The very next day, a wave of Indian pharmaceutical companies launched their own generic semaglutide. Because so many launched at once, prices collapsed — in some cases by up to 90% compared with the branded version.
This matters for three reasons. First, a medicine that cost tens of thousands of rupees a month suddenly became far more affordable. Second, India’s regulator reportedly required Phase III data from Indian patients — not just bioequivalence — before approval, which adds a layer of local testing. Third, the regulator (CDSCO) reportedly restricted promotional activity and tightened pharmacy checks, because a prescription weight-loss drug carries real risks if misused.
Important: Cheaper and widely available does NOT mean safe to self-prescribe. Semaglutide remains prescription-only in India for good medical reasons. The rest of this guide explains why.
Semaglutide brands in India 2026: price list
Here are the major brands of semaglutide in India in 2026, with indicative prices from public sources. Treat these as rough ranges for comparison only — actual prices vary by city, pharmacy, dose, and format, and change frequently.
| Brand(s) | Company | Indicative price | Form |
|---|---|---|---|
| SUNDAE / Semanat | Eris / Natco | From ~Rs 220/shot; vial ~Rs 1,290–1,750/mo | Vial |
| GLIPIQ | Glenmark | ~Rs 325–440/week | Vial & pen |
| Noveltreat / Sematrinity | Sun Pharma | ~Rs 900–2,000/shot | Prefilled pen |
| Semasize / Obesema | Alkem | ~Rs 1,800–3,500/month | Prefilled pen |
| Semaglyn / Mashema | Zydus | ~Rs 2,200/month average | Reusable pen |
| Semanext / Livarise | Lupin (Zydus licence) | ~Rs 8,749 per cartridge | Reusable pen |
| Obeda / Usema | Dr. Reddy’s + USV | ~Rs 4,200/month | Prefilled pen |
| Semabest | MSN Laboratories | ~Rs 3,990/month | Prefilled pen |
| Sembolic / Semalix | Torrent | Inj. from ~Rs 3,999/mo; oral tablets too | Injection & oral |
| Samakind | Mankind | Price not yet confirmed | Pen |
Innovator (branded) semaglutide — Ozempic, Rybelsus and Wegovy from Novo Nordisk — typically costs more, roughly Rs 3,999–16,400/month depending on product and dose. Novo Nordisk reportedly cut Indian prices by around 48% in April 2026 in response to the generics.
Semaglutide vs Mounjaro (tirzepatide): what’s the difference?
People often lump these together, but they are different molecules.
| Factor | Semaglutide | Tirzepatide (Mounjaro) |
|---|---|---|
| Drug class | GLP-1 receptor agonist | Dual GIP + GLP-1 receptor agonist |
| Innovator brands | Ozempic, Rybelsus, Wegovy | Mounjaro (Eli Lilly) |
| Generics in India | Yes — patent expired Mar 2026 | No — still under patent |
| Indicative price | From ~Rs 220/shot (generic) | ~Rs 13,125–25,781/month |
| Forms | Injection + oral tablet | Injection |
The practical difference in 2026: semaglutide in India now has cheap generics, while Mounjaro (tirzepatide) is still a single branded product and remains expensive. Which one suits a patient is a medical decision — it depends on their diabetes control, weight goals, other conditions, and how they tolerate side effects. That is a conversation for a doctor, not a website.
Semaglutide side effects and safety in India
No weight-loss or diabetes drug is a shortcut without trade-offs. Semaglutide in India carries the same well-documented side effects, which is exactly why it needs a prescription and medical supervision.
Common side effects
- Nausea, vomiting, and feeling full quickly — especially when starting or increasing the dose.
- Diarrhoea or constipation.
- Reduced appetite and, for some, tiredness.
More serious concerns (why a doctor must be involved)
- Risk of low blood sugar, particularly when combined with other diabetes medicines.
- Rare but serious risks such as pancreatitis and gallbladder problems.
- It is not suitable for everyone — including certain thyroid cancer histories and during pregnancy.
Please read this carefully: Semaglutide is a medicine, not a lifestyle supplement. Using it without medical supervision — or buying it from unverified online sellers — is dangerous. If you are struggling with weight or diabetes, the safest first step is a doctor, not a pharmacy shortcut. Rapid or unsupervised weight loss can harm your health.
What semaglutide in India means for pharmacy students
If you are a D.Pharm, B.Pharm, or Pharm.D student, this is the most important real-world pharmacology story of your course right now. A few reasons semaglutide in India belongs in your notes:
- GLP-1 receptor agonists are a core topic in pharmacology and will increasingly appear in exams like GPAT and recruitment tests.
- The generics launch is a live case study in patent expiry, bioequivalence, Schedule H regulation, and CDSCO’s role — exactly the jurisprudence and pharmacology syllabus you study.
- As future pharmacists, you will counsel patients on these drugs — on side effects, injection technique, and the importance of a prescription. Knowing the brands and the science makes you genuinely useful.
For the full pharmacology background, see our Drug Inspector syllabus guide and free pharmacy exam mock tests.
Frequently asked questions
Q: Is semaglutide in India available in 2026?
A: Yes, semaglutide in India is available. After the patent expired on 20 March 2026, more than eight Indian companies launched generic semaglutide. It is sold under many brand names as injections and, in limited cases, oral tablets. It remains prescription-only.
Q: What is the price of semaglutide in India?
A: Generic semaglutide in India starts from around Rs 220 per shot, with monthly costs commonly ranging from roughly Rs 1,300 to Rs 8,700 depending on brand, dose and format. Branded Ozempic, Rybelsus and Wegovy usually cost more. Prices change often — confirm with a pharmacist.
Q: Is generic semaglutide in India safe?
A: Generic semaglutide in India, once approved by the DCGI, must meet regulatory standards, and India reportedly required Phase III data from Indian patients. But ‘approved’ does not mean safe to self-prescribe. It is a prescription medicine with real side effects and must be used under a doctor’s supervision.
Q: What is the difference between semaglutide and Mounjaro?
A: Semaglutide is a GLP-1 receptor agonist (Ozempic, Rybelsus, Wegovy). Mounjaro is tirzepatide, a dual GIP and GLP-1 agonist — a different molecule still under patent and more expensive. Only a doctor can judge which is appropriate for a patient.
Q: Can I buy semaglutide in India without a prescription?
A: No. Semaglutide is a Schedule H drug and legally requires a valid prescription. Buying it without one, or from unverified online sellers, is unsafe and not advised.
Q: Does semaglutide in India work for weight loss in non-diabetics?
A: Semaglutide in India (as Wegovy) is approved for chronic weight management in eligible people, and it reduces appetite. However, who should use it, at what dose, and for how long is a medical decision. It is not a casual slimming product.
The bottom line
Semaglutide in India went from an expensive, patent-protected drug to an affordable, widely available one almost overnight in 2026. That is genuinely good news for patients who need it — but affordability is not a reason to skip the doctor. The science is powerful, the side effects are real, and it remains a prescription medicine for good reason.
If you take one thing from this guide: semaglutide in India is a tool that works best under medical supervision, not a shortcut to buy on your own.
Final medical disclaimer: This article is educational and not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified doctor before starting any medicine. Noteskarts does not sell or recommend buying prescription drugs.
Facts and prices in this guide were checked against public sources in November 2026 and are indicative only. Drug prices, brand availability and regulations change frequently — verify current details with a pharmacist or your doctor.
Related reading on Noteskarts
- UPSC Drug Inspector Syllabus 2026: Complete Subject-Wise Guide
- RRB Pharmacist Syllabus 2026: Exam Pattern, Vacancy & Salary
- Free Pharmacy Exams Mock Test 2026
- How to Become a Pharmacist in USA from India
Official source (external)
CDSCO (Central Drugs Standard Control Organisation) — India’s drug regulator
